NewsBenzingaHC Wainwright & Co.维持对Anixa Biosciences的买入评级，将目标股价下调至6美元 HC Wainwright & Co.维持对Anixa Biosciences的买入评级，将目标股价下调至6美元 Benzinga 2026.09.22 17:09 (GMT+0) Open on Benzinga Other news Here’s How Much You Would Have Made Owning Spotify Technology Stock In The Last 5 Years Innate Pharma S.A. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:IPHA) 2026-09-22 $100 Invested In Simpson Manufacturing Co 10 Years Ago Would Be Worth This Much Today FibroBiologics, Inc. (FBLG) Discusses Strategy and Clinical Progress in Fibroblast-Based Cell Therapies for Chronic Diseases Transcript Vicor: VPD Licensing Is A Game Changer (NASDAQ:VICR) Exclusive | $5 Billion Flurry of Nearly Identical Kalshi Trades Draws Scrutiny
FibroBiologics, Inc. (FBLG) Discusses Strategy and Clinical Progress in Fibroblast-Based Cell Therapies for Chronic Diseases Transcript
